Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
76.45
-1.04 (-1.34%)
At close: Aug 11, 2026, 4:00 PM EDT
76.00
-0.45 (-0.59%)
Pre-market: Aug 12, 2026, 7:17 AM EDT
Cytokinetics Employees
Cytokinetics had 673 employees as of December 31, 2025. The number of employees increased by 175 or 35.14% compared to the previous year.
Employees
673
Change (1Y)
175
Growth (1Y)
35.14%
Revenue / Employee
$100,550
Profits / Employee
-$1,328,383
Market Cap
10.63B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 673 | 175 | 35.14% |
| Dec 31, 2024 | 498 | 75 | 17.73% |
| Dec 31, 2023 | 423 | 14 | 3.42% |
| Dec 31, 2022 | 409 | 156 | 61.66% |
| Dec 31, 2021 | 253 | 69 | 37.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,220 |
| Madrigal Pharmaceuticals | 915 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
CYTK News
- 1 day ago - Cytokinetics price target raised to $112 from $106 at Truist - TheFly
- 4 days ago - Cytokinetics price target raised to $85 from $83 at BofA - TheFly
- 4 days ago - Cytokinetics price target raised to $112 from $102 at Needham - TheFly
- 4 days ago - Cytokinetics price target lowered to $112 from $117 at RBC Capital - TheFly
- 5 days ago - Cytokinetics price target raised to $110 from $105 at Citizens - TheFly
- 5 days ago - Cytokinetics Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Cytokinetics Earnings release: Q2 2026 - Filings
- 5 days ago - Cytokinetics Quarterly report: Q2 2026 - Filings